RxDoctor Payments Data

Patrick Daley

Pediatrics · Tulsa, OKNPI 1932183548

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (40.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Supernus Pharmaceuticals, Inc. accounts for 75.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $4,018 and has fallen 99.6% since, to $15 in 2025. Among pediatrics clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,884in general payments, 2019–2025

Across 75 payments — averaging $65.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$4K
  • Tris Pharma Inc$228
  • Takeda Pharmaceuticals U.S.A., Inc.$178
  • GSK$150
  • Ironshore Pharmaceuticals Inc.$139
  • Corium, LLC$99
  • plus $387 from 13 others

What the payments were for

  • Speaking & faculty fees$2,00041%
  • Travel & lodging$1,31827%
  • Food & beverage$1,56632%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,884 in reported general payments places this provider in the 95th percentile of 568 pediatrics providers in Oklahoma.

See all pediatrics providers in Oklahoma →

Other pediatrics in Tulsa

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →